United States · FDA National Drug Code directory
AZACITIDINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70121-1237_38a5005c-7a0b-48c6-bba5-a996ccf1c847
- Product NDC
- 70121-1237
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- AZACITIDINE
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220209
- Source listing expiry
- 20261231
Source-listed ingredients
- AZACITIDINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (70121-1237-1) · 70121-1237-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →